Estamos no ar no ! Saiba mais

ADARx Pharmaceuticals, Inc. Common Stock

ADRX

Valor de mercado US$ 1,89 bi

17,65 USD

-0,05

0,28%

No fechamento Atualizado 16 de out. 16:00 EDT

Pré-mercado

Após o fechamento do mercado

17,83

+0,18

1,02%

1 dia

-0,28%

5 dias

-0,73%

1 mês

-8,79%

3 meses

-8,79%

6 meses

-8,79%

No acumulado do ano

-8,79%

1 ano

-8,79%

5 anos

-8,79%

10 anos

-8,79%

Sobre: Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.

Saúde Biotecnologia